In this first episode, we talk to Dr Ajay Aggarwal about an exciting new study to evaluate if artificial intelligence (AI) can transform the way we plan radiotherapy in low- and middle-income countries (LMIC). The study is called the ARCHERY (short for “Artificial Intelligence based radiotherapy treatment planning for Cervical, Head and Neck and Prostate cancer”). Ajay explains how this study could improve global access to radiotherapy by automatising parts of radiotherapy treatment planning using AI. He also highlights the importance of evaluating the implementation and cost-effectiveness of this AI approach, as well as its plan to build capacity in LMIC.

60

11/8/2022

New Insights from the TARGIT-A trial of radiotherapy during lumpectomy for breast cancer

14

12/1/2021

Invited talk at the Association of Breast Surgeons of India Conference, 26 Nov 2021

15

12/1/2021

TARGIT-IORT for breast cancer NCRI conference Nov 2021 - 5-Min Short talk

13

12/1/2021

Invited talk at the NHS Oncology Conference 23 Nov 2021

16

12/1/2021

Professor Gary Royle Professor of Medical Radiation Physics, UCL Department of Medical Physics and Biomedical Engineering Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 The cancer treatment revolution and how we afford it? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.

713

6/4/2019

Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT. Nathan J Coombs, Joel M Coombs, Uma J Vaidya, Julian Singer, Max Bulsara, Jeffrey S Tobias, Frederik Wenz, David J Joseph, Douglas A Brown, Richard Rainsbury, Tim Davidson, Douglas J A Adamson, Samuele Massarut, David Morgan, Ingrid Potyka, Tammy Corica, Mary Falzon, Norman Williams, Michael Baum, Jayant S Vaidya BMJ Open 2016;6:e010703. http://bmjopen.bmj.com/content/6/5/e010703.full http://blogs.bmj.com/bmjopen/2016/05/09/radiotherapy-during-surgery-could-save-millions-of-travel-miles-and-tonnes-of-co2/ The use of TARGIT intraoperative radiotherapy for eligible patients with breast cancer significantly reduces their journeys for treatment and has environmental benefits: 5 million miles of travel, 170 000 woman-hours and 1200 tonnes of CO2 (a forest of 100 hectares) per year in the UK

48

11/24/2018

The Royal Society - Experts and patients discussing TARGIT IORT for breast cancer, 31 October 2018 http://www.targit.org.uk

72

11/20/2018